We’re thrilled to announce EthOss Regeneration Ltd will enter an exciting new market after securing approval to distribute in Russia.
EthOss®, our groundbreaking flagship product, will be distributed by Southern Implants Russia after regulatory approval was secured from Russia’s Federal Service for Surveillance in Healthcare (Roszdravnadzor).
The product, launched in 2015, has gained significant traction within the dental implantology sector thanks to a cutting-edge composition that encourages new bone growth during dental implant procedures.
The distribution deal in Russia follows recent agreements to sell EthOss® in Chile, Colombia, France and Saudi Arabia. The company already has established markets in Australia, the Middle East and Asia.
International expansion has seen EthOss’s export sales grow 61 percent year-on-year and, earlier this year, we were proud to be awarded the highly-coveted Queens Award for Enterprise in the international trade category.
Dr Paul Harrison, managing director of EthOss Regeneration, said: “We are looking forward to working with Southern Implants Russia to offer EthOss® to patients and practitioners in Russia.
“It was a rigorous approval process that took several years and this is a large market for us which should provide a big boost to our already-thriving export sales.
“This is a hugely exciting time for the company and, despite the challenges of the Covid-19 pandemic, we have been able to rapidly grow the international side of the business. We will continue working with partners across the world to increase the global reach of our pioneering product.”